Skyepharma Share News (SKP)

Skypharma annual losses widen

LONDON (Thomson Financial) - Skyepharma PLC reported widening losses for the year on the cost of the final stage trials of its experimental asth
[26 Apr '07]

Skyepharma says receives French approval for Parkinson's disease drug ropinirole

LONDON (Thomson Financial) - Skyepharma PLC said it has received regulatory approval in France for Parkinson's disease drug ropinirole prolonged
[23 Apr '07]

Skyepharma says US FDA accepts GSK filing for REQUIP XL tablets UPDATE

(Adds Parkinson's disease figures in the US, share price) LONDON (Thomson Financial) - Skyepharma PLC said the US Food and Drug Administrati
[13 Apr '07]

Skyepharma says US FDA accepts GSK filing for REQUIP extended-release tablets

LONDON (Thomson Financial) - Skyepharma PLC said the US Food and Drug Administration has accepted for filing the application by its partner, Gla
[13 Apr '07]

Skyepharma completes sale of injectables ops, financial restructuring

LONDON (AFX) - Skyepharma PLC said it has completed the disposal of its injectables business, thus rendering plans to raise 14.8 mln stg via a p
[26 Mar '07]

Skyepharma says Zileuton partner signs co-promotional deal with Merck affiliate

LONDON (AFX) - Skyepharma PLC said Critical Therapeutics, its partner for Zileuton oral anti-inflammatory asthma drug, has signed a co-promotion
[15 Mar '07]

Skyepharma finance director Peter Grant buys 100,000 company shares

LONDON (AFX) - SkyePharma PLC said that finance director Peter Grant has purchased 100,000 of its shares at a price of 24 pence each and that th
[29 Jan '07]

RPT SkyePharma to sell injectable ops to Blue Acquisition - UPDATE

(repeating to clarify details on Christofferson, Robb & Company) LONDON (AFX) - SkyePharma PLC said it plans to sell its injectable business
[9 Jan '07]